Central Laboratory, Jinhua Municipal Central Hospital, People's Republic of China.
Department of Grass-roots Guidance, Jinhua Municipal Central Hospital, People's Republic of China.
Diabetes Res Clin Pract. 2020 Jul;165:108272. doi: 10.1016/j.diabres.2020.108272. Epub 2020 Jun 16.
BACKGROUND: Several studies have indicated that high albuminuria is associated with renal function decline. However, the relationship between the urinary albumin-to-creatinine ratio (ACR) and risk of developing tubular injury remains unclear. Our aim was to investigate the association of ACR with the risk of developing tubular impairment in patients with type 2 diabetes. METHODS: This longitudinal observational study compared baseline with follow-up data in 183 patients with type 2 diabetes. ACR, urinary alpha-1-microglobulin-to-creatinine ratio (A1MCR) and estimated glomerular filtration rate (eGFR) were used to evaluate albuminuira, tubular injury and glomerular filtration function, respectively. RESULTS: Levels of high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and A1MCR were significantly different at the two-year follow-up compared with baseline levels. Among patients both with baseline ACR above and below 30 mg/g, the percentage with A1MCR > 15 mg/g clearly increased after follow-up (P < 0.05). The risk of A1MCR rising from normal ranges to >15 mg/g over the follow-up increased with increasing baseline ACR values lower baseline eGFR. Among the patients with baseline ACR > 63.10 mg/g, all showed increased A1MCR values at follow-up compared with baseline. In the multivariate regression analysis, the patients with baseline ACR > 63.10 mg/g had a strong risk of A1MCR rising from normal to >15 mg/g (odds ratio (OR) = 11.12, P = 0.001) over the follow-up, while the males had a 2.89-fold risk of A1MCR increasing from normal to >15 mg/g compared with females. CONCLUSION: Baseline ACR level is related to increased risk of developing renal tubular injury; in particular, this association is much stronger in patients with type 2 diabetes and baseline ACR > 63.10 mg/g.
背景:多项研究表明,白蛋白尿与肾功能下降有关。然而,尿白蛋白与肌酐比值(ACR)与肾小管损伤风险之间的关系尚不清楚。我们的目的是探讨 ACR 与 2 型糖尿病患者肾小管损伤风险的关系。
方法:这是一项纵向观察性研究,比较了 183 例 2 型糖尿病患者的基线与随访数据。ACR、尿α-1 微球蛋白与肌酐比值(A1MCR)和估算肾小球滤过率(eGFR)分别用于评估白蛋白尿、肾小管损伤和肾小球滤过功能。
结果:与基线相比,高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和 A1MCR 在两年随访时的水平有显著差异。在基线 ACR 高于和低于 30mg/g 的患者中,随访后 A1MCR>15mg/g 的比例明显增加(P<0.05)。随着基线 ACR 值的降低和基线 eGFR 的降低,A1MCR 从正常范围升高到>15mg/g 的风险增加。在基线 ACR>63.10mg/g 的患者中,与基线相比,所有患者的 A1MCR 值在随访时均升高。在多变量回归分析中,基线 ACR>63.10mg/g 的患者在随访期间 A1MCR 从正常升高到>15mg/g 的风险显著增加(比值比(OR)=11.12,P=0.001),而男性与女性相比,A1MCR 从正常升高到>15mg/g 的风险增加 2.89 倍。
结论:基线 ACR 水平与发生肾小管损伤的风险增加有关;特别是在基线 ACR>63.10mg/g 的 2 型糖尿病患者中,这种相关性更强。